Jecure Therapeutics is focused on the discovery of innovative therapeutics for the treatment of non-alcoholic steatohepatitis.
Jecure Therapeutics is focused on the discovery of innovative therapeutics for the treatment of non-alcoholic steatohepatitis.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 15, 2017 | Series A | $20M | 1 |
Versant Ventures
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
Yes | Series A |